[EN] USE OF CARBONYLAMINO DERIVATIVES AGAINST CNS DISORDERS<br/>[FR] UTILISATION DE DERIVES CARBONYLAMINO CONTRE LES TROUBLES DU SYSTEME NERVEUX CENTRAL
申请人:HOFFMANN LA ROCHE
公开号:WO2001027070A1
公开(公告)日:2001-04-19
The present invention is concerned with the use of carbonylamino derivatives of general formula (I) wherein R signifies lower alkyl, lower alkenyl, lower alkinyl, cycloalkyl, lower alkoxy or CF3; R1 signifies hydrogen or lower alkyl; R?2 and R3¿ signify, independently from each other, hydrogen, halogen or nitro; Y signifies CH or N; n is 0-6; m is 0-2; as well as with their pharmaceutically acceptable salts for the treatment of diseases, which relate to metabotropic glutamate receptor antagonists and/or agonists.